MiNK Therapeutics, Inc. (INKT)
(Delayed Data from NSDQ)
$0.70 USD
+0.03 (4.02%)
Updated Oct 14, 2024 12:39 PM ET
3-Hold of 5 3
D Value A Growth A Momentum B VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
INKT 0.70 +0.03(4.02%)
Will INKT be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for INKT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for INKT
MiNK Therapeutics, Inc. (INKT) Upgraded to Strong Buy: Here's What You Should Know
New Strong Buy Stocks for July 11th
INKT: What are Zacks experts saying now?
Zacks Private Portfolio Services
All You Need to Know About MiNK Therapeutics, Inc. (INKT) Rating Upgrade to Buy
Other News for INKT
Analysts Are Bullish on These Healthcare Stocks: Black Diamond Therapeutics (BDTX), MiNK Therapeutics (INKT)
MiNK Therapeutics Inc (INKT) Q2 2024 Earnings Call Highlights: Strategic Advances Amid ...
MiNK Therapeutics, Autonomous Therapeutics enter research collaboration
12 Health Care Stocks Moving In Friday's After-Market Session
MiNK Therapeutics to Participate in H.C. Wainwright Global Investment Conference